Cibus (CBUS) to Release Quarterly Earnings on Thursday

Key Points

• Cibus (NASDAQ:CBUS) is set to report its Q2 2025 earnings on August 14th, with analysts predicting a loss of ($0.69) per share and revenue of $1.15 million.
• The company's previous quarterly results showed a loss of ($0.74) per share, missing estimates, while revenue was $1.03 million against a forecast of $1.15 million.
• Institutional investor Bank of America Corp DE increased its stake in Cibus by 113.4%, now holding about 33.81% of the company's stock.

Cibus (NASDAQ:CBUS - Get Free Report) is anticipated to release its Q2 2025 earnings data after the market closes on Thursday, August 14th. Analysts expect the company to announce earnings of ($0.69) per share and revenue of $1.15 million for the quarter.

Cibus (NASDAQ:CBUS - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The company reported ($0.74) EPS for the quarter, missing the consensus estimate of ($0.70) by ($0.04). The business had revenue of $1.03 million during the quarter, compared to analyst estimates of $1.15 million. Cibus had a negative net margin of 5,784.87% and a negative return on equity of 53.20%. On average, analysts expect Cibus to post $-3 EPS for the current fiscal year and $-3 EPS for the next fiscal year.

Cibus Stock Performance

Shares of CBUS stock traded down $0.04 during trading on Friday, hitting $1.44. The company had a trading volume of 186,957 shares, compared to its average volume of 269,080. The firm has a market capitalization of $47.03 million, a P/E ratio of -0.13 and a beta of 1.75. Cibus has a one year low of $1.38 and a one year high of $8.65. The stock's 50-day moving average price is $1.63 and its 200 day moving average price is $2.02.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Cibus stock. Bank of America Corp DE boosted its position in Cibus, Inc. (NASDAQ:CBUS - Free Report) by 113.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 35,536 shares of the company's stock after acquiring an additional 18,885 shares during the period. Bank of America Corp DE owned 0.13% of Cibus worth $99,000 as of its most recent SEC filing. Institutional investors and hedge funds own 33.81% of the company's stock.

Wall Street Analyst Weigh In

Separately, Canaccord Genuity Group cut their price objective on shares of Cibus from $18.00 to $17.50 and set a "buy" rating for the company in a research report on Monday, May 12th.

Cibus Company Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.